Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 294213, 6 pages
http://dx.doi.org/10.1155/2015/294213
Review Article

Inverse Association between Prediagnostic IgE Levels and the Risk of Brain Tumors: A Systematic Review and Meta-Analysis

Department of Neurosurgery, Central Hospital of Xuzhou, Affiliated Hospital of Southeast University, Xuzhou, Jiangsu 221009, China

Received 16 July 2014; Revised 21 August 2014; Accepted 25 August 2014

Academic Editor: Aurelio Ariza

Copyright © 2015 Chong Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. T. Ostrom, H. Gittleman, P. Farah et al., “CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010,” Neuro-Oncology, vol. 15, supplement 2, pp. ii1–ii56, 2013. View at Google Scholar
  2. H. Ohgaki and P. Kleihues, “Epidemiology and etiology of gliomas,” Acta Neuropathologica, vol. 109, no. 1, pp. 93–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Saraf, B. J. McCarthy, and J. L. Villano, “Update on meningiomas,” The Oncologist, vol. 16, no. 11, pp. 1604–1613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. T. Ostrom and J. S. Barnholtz-Sloan, “Current state of our knowledge on brain tumor epidemiology,” Current Neurology and Neuroscience Reports, vol. 11, no. 3, pp. 329–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Guo, L. Shi, M. Li et al., “Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk,” Tumor Biology, vol. 35, no. 1, pp. 573–579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Zong, L. Cao, C. Ma et al., “Association between the G870A polymorphism of Cyclin D1 gene and glioma risk,” Tumour Biology, 2014. View at Google Scholar
  7. R. G. Hamilton, D. W. MacGlashan Jr., and S. S. Saini, “IgE antibody-specific activity in human allergic disease,” Immunologic Research, vol. 47, no. 1–3, pp. 273–284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. W. E. Paul and J. Zhu, “How are T(H)2-type immune responses initiated and amplified?” Nature Reviews Immunology, vol. 10, no. 4, pp. 225–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. H. Josephs, J. F. Spicer, C. J. Corrigan, H. J. Gould, and S. N. Karagiannis, “Epidemiological associations of allergy, IgE and cancer,” Clinical and Experimental Allergy, vol. 43, no. 10, pp. 1110–1123, 2013. View at Publisher · View at Google Scholar
  10. M. C. Turner, “Epidemiology: allergy history, IgE, and cancer,” Cancer Immunology, Immunotherapy, vol. 61, no. 9, pp. 1493–1510, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. W. G. Cochran, “The comparison of percentages in matched samples,” Biometrika, vol. 37, no. 3-4, pp. 256–266, 1950. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  12. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Mantel and W. Haenszel, “Statistical aspects of the analysis of data from retrospective studies of disease,” Journal of the National Cancer Institute, vol. 22, no. 4, pp. 719–748, 1959. View at Google Scholar
  15. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. Stuck, L. Z. Rubenstein, and D. Wieland, “Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity,” British Medical Journal, vol. 316, no. 7129, pp. 469–471, 1998. View at Publisher · View at Google Scholar
  17. E. S. Amirian, D. Marquez-Do, M. L. Bondy, and M. E. Scheurer, “Antihistamine use and immunoglobulin E levels in glioma risk and prognosis,” Cancer Epidemiology, vol. 37, no. 6, pp. 908–912, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. F. C. F. Calboli, D. G. Cox, J. E. Buring et al., “Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies,” Journal of the National Cancer Institute, vol. 103, no. 21, pp. 1588–1595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Schlehofer, B. Siegmund, J. Linseisen et al., “Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European prospective investigation into cancer and nutrition cohort,” Allergy, vol. 66, no. 11, pp. 1434–1441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Schwartzbaum, B. Ding, T. B. Johannesen et al., “Association between prediagnostic IgE levels and risk of glioma,” Journal of the National Cancer Institute, vol. 104, no. 16, pp. 1251–1259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Wiemels, J. K. Wiencke, J. Patoka et al., “Reduced immunoglobulin E and allergy among adults with glioma compared with controls,” Cancer Research, vol. 64, no. 22, pp. 8468–8473, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. L. Wiemels, D. Wilson, C. Patil et al., “IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era,” International Journal of Cancer, vol. 125, no. 3, pp. 680–687, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Wiemels, M. Wrensch, J. D. Sison et al., “Reduced allergy and immunoglobulin e among adults with intracranial meningioma compared to controls,” International Journal of Cancer, vol. 129, no. 8, pp. 1932–1939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Rittmeyer and A. Lorentz, “Relationship between allergy and cancer: an overview,” International Archives of Allergy and Immunology, vol. 159, no. 3, pp. 216–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Olson, M. Hsu, J. L. Wiemels et al., “Serum immunoglobuline and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial,” Cancer Epidemiology, Biomarkers & Prevention, vol. 23, no. 7, pp. 1414–1420, 2014. View at Google Scholar
  26. S. K. Dikalioti, E. T. Chang, N. Dessypris et al., “Allergy-associated symptoms in relation to childhood non-Hodgkin's as contrasted to Hodgkin's lymphomas: a case-control study in Greece and meta-analysis,” European Journal of Cancer, vol. 48, no. 12, pp. 1860–1866, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Vojtechova and R. M. Martin, “The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis,” Cancer Causes and Control, vol. 20, no. 7, pp. 1091–1105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Jensen-Jarolim, G. Achatz, M. C. Turner et al., “AllergoOncology: the role of IgE-mediated allergy in cancer,” Allergy, vol. 63, no. 10, pp. 1255–1266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. N. Karagiannis, D. H. Josephs, P. Karagiannis et al., “Recombinant IgE antibodies for passive immunotherapy of solid tumours: From concept towards clinical application,” Cancer Immunology, Immunotherapy, vol. 61, no. 9, pp. 1547–1564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Singer and E. Jensen-Jarolim, “IgE-based immunotherapy of cancer: challenges and chances,” Allergy, vol. 69, no. 2, pp. 137–149, 2014. View at Publisher · View at Google Scholar
  31. H. Zhao, W. Cai, S. Su, D. Zhi, J. Lu, and S. Liu, “Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects,” Tumor Biology, vol. 35, no. 4, pp. 3875–3880, 2014. View at Google Scholar
  32. J. L. Wiemels, J. K. Wiencke, K. T. Kelsey et al., “Allergy-related polymorphisms influence glioma status and serum IgE levels,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 6, pp. 1229–1235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. D. Howard, G. H. Koppelman, J. Xu et al., “Gene-gene interaction in asthma: Il4ra and il13 in a dutch population with asthma,” The American Journal of Human Genetics, vol. 70, no. 1, pp. 230–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. D. M. Backes, A. Siddiq, D. G. Cox et al., “Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma,” Journal of Neuro-Oncology, vol. 113, no. 2, pp. 229–238, 2013. View at Publisher · View at Google Scholar · View at Scopus